Total Funding
88
79
Total FundingAngel raised
Growth Score
1 pts
Heat Score
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
56634
Cell rejuvenation with small molecules — no gene editing required. Starting with cancer, extending to longevity.
About the Company
CellRep is a biotech company using an AI-powered discovery platform to identify small molecules that enhance the manufacturing of cell therapies. Applied during ex vivo CAR-T production and washed out before infusion, CellRep's compounds improve T cell polyfunctionality and stem-like phenotype while reducing exhaustion, addressing the core
failure modes that limit efficacy in solid tumors. Because the compounds act as manufacturing reagents rather than administered drugs, they integrate into existing CAR-T processes without requiring a separate IND, compressing the path to the clinic. Founded in 2024, CellRep operates across Houston (embedded at Baylor College of Medicine), Bogotá, and Buenos Aires.
